Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 28% ± 10% | |
type I pneumocyte | 12 studies | 64% ± 17% | |
epithelial cell | 11 studies | 37% ± 19% | |
endothelial cell of artery | 11 studies | 32% ± 14% | |
mesothelial cell | 10 studies | 38% ± 12% | |
capillary endothelial cell | 10 studies | 36% ± 11% | |
basal cell | 8 studies | 34% ± 14% | |
secretory cell | 7 studies | 25% ± 16% | |
club cell | 6 studies | 33% ± 10% | |
ciliated cell | 5 studies | 35% ± 13% | |
duct epithelial cell | 4 studies | 32% ± 5% | |
vein endothelial cell | 4 studies | 39% ± 19% | |
endothelial cell of vascular tree | 4 studies | 17% ± 1% | |
myoepithelial cell | 4 studies | 41% ± 8% | |
neutrophil | 3 studies | 29% ± 1% | |
squamous epithelial cell | 3 studies | 43% ± 23% | |
progenitor cell | 3 studies | 35% ± 25% | |
placental villous trophoblast | 3 studies | 29% ± 10% | |
type II pneumocyte | 3 studies | 24% ± 5% | |
mucus secreting cell | 3 studies | 39% ± 9% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 22% ± 3% | |
pancreatic ductal cell | 3 studies | 61% ± 15% | |
goblet cell | 3 studies | 31% ± 6% | |
brush cell | 3 studies | 31% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 3644.01 | 358 / 359 | 95% | 56.17 | 271 / 286 |
intestine | 93% | 1583.80 | 894 / 966 | 97% | 65.04 | 510 / 527 |
prostate | 91% | 2477.01 | 222 / 245 | 98% | 67.30 | 494 / 502 |
lung | 100% | 6714.54 | 577 / 578 | 87% | 33.06 | 1006 / 1155 |
esophagus | 98% | 4240.08 | 1419 / 1445 | 85% | 35.05 | 155 / 183 |
thymus | 100% | 4862.11 | 650 / 653 | 83% | 52.42 | 501 / 605 |
pancreas | 87% | 1284.64 | 286 / 328 | 90% | 67.36 | 161 / 178 |
breast | 99% | 3380.84 | 456 / 459 | 64% | 19.16 | 717 / 1118 |
kidney | 82% | 1235.17 | 73 / 89 | 47% | 11.48 | 419 / 901 |
uterus | 32% | 310.95 | 54 / 170 | 78% | 38.06 | 357 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.95 | 1 / 1 |
ovary | 5% | 41.17 | 9 / 180 | 93% | 35.40 | 398 / 430 |
spleen | 95% | 1986.32 | 229 / 241 | 0% | 0 | 0 / 0 |
adipose | 92% | 2769.53 | 1109 / 1204 | 0% | 0 | 0 / 0 |
heart | 90% | 1605.49 | 779 / 861 | 0% | 0 | 0 / 0 |
bladder | 19% | 202.33 | 4 / 21 | 67% | 35.58 | 339 / 504 |
peripheral blood | 78% | 10596.80 | 727 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 21.42 | 32 / 45 |
skin | 41% | 468.01 | 745 / 1809 | 26% | 5.74 | 123 / 472 |
muscle | 57% | 522.10 | 458 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 41% | 550.54 | 547 / 1335 | 0% | 0 | 0 / 0 |
brain | 39% | 394.32 | 1021 / 2642 | 1% | 0.12 | 7 / 705 |
liver | 2% | 15.88 | 4 / 226 | 13% | 5.86 | 52 / 406 |
adrenal gland | 3% | 23.48 | 7 / 258 | 2% | 0.53 | 4 / 230 |
eye | 0% | 0 | 0 / 0 | 4% | 0.52 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0021766 | Biological process | hippocampus development |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0031100 | Biological process | animal organ regeneration |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0043312 | Biological process | neutrophil degranulation |
GO_0006909 | Biological process | phagocytosis |
GO_0042742 | Biological process | defense response to bacterium |
GO_0051054 | Biological process | positive regulation of DNA metabolic process |
GO_0070848 | Biological process | response to growth factor |
GO_0005886 | Cellular component | plasma membrane |
GO_0012506 | Cellular component | vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0043025 | Cellular component | neuronal cell body |
GO_0042581 | Cellular component | specific granule |
GO_0030425 | Cellular component | dendrite |
GO_0005737 | Cellular component | cytoplasm |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0030424 | Cellular component | axon |
GO_0005634 | Cellular component | nucleus |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0019834 | Molecular function | phospholipase A2 inhibitor activity |
Gene name | ANXA3 |
Protein name | Annexin A3 Annexin Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III) |
Synonyms | ANX3 |
Description | FUNCTION: Inhibitor of phospholipase A2, also possesses anti-coagulant properties. Also cleaves the cyclic bond of inositol 1,2-cyclic phosphate to form inositol 1-phosphate. |
Accessions | ENST00000514171.5 P12429 ENST00000508214.1 ENST00000512542.5 D6RAZ8 ENST00000512884.5 ENST00000264908.11 D6RCA8 ENST00000512373.5 ENST00000503570.6 D6RA82 D6RFJ9 D6RFG5 |